{
      "ptx_code": "PTX232",
      "chem_name": "Pentachlorophenol",
      "casrn": "87-86-5",
      "dtxsid": "DTXSID7021106",
      "smiles": "OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl",
      "inchikey": "IZUPBVBPLAPZRR-UHFFFAOYSA-N",
      "label": "PTX232 | Pentachlorophenol",
      "drugbank_id": "",
      "use_class": "Pesticide",
      "tox_class": "Genotoxicity; Hepatotoxicity; Neurotoxicity; Immunotoxicity; Hematotoxicity",
      "chem_name_user": "Pentachlorophenol",
      "mw_g_mol": "266.32",
      "solubility_h2o_mol_liter": "0.000151944",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "2.45947e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "5.99746814232055",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "4.49",
      "pka_base": "",
      "source_pka": "ACD/GALAS",
      "log_kow_liter_liter": "5.12",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "4.06999999999999",
      "source_dlipw": "Kow QSAR (\u00e2\u02c6\u2020mw = 1)",
      "freely_dissolved_fraction": "0.00765501100351666",
      "density_kg_liter": "1.764",
      "source_density": "COMPTOX",
      "baseline_drerio": "15.5131502929341",
      "baseline_dmagna": "15.2264969556793",
      "baseline_celegans": "35.7519718745026",
      "baseline_xlaevis": "25.3016590997726",
      "baseline_dmelanogaster": "133.531891224938",
      "baseline_cells": "0.000143265168509922",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.09669644136413e-06",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "Pentachlorophenol prevents sulfation by inhibiting phenol-sulfotransferases. (A92); Pentachlorophenol inhibits acetylcholinesterase in erythrocyte membranes. (A93); Pentachlorophenol competes with thyroxine for uptake into cerebrospinal fluid at the T4 binding site of transthyretin. (L127); Pentachlorophenol inhibits O-acetyltransferases. (A94); Pentachlorophenol causes adverse effects on thyroid homeostasis, decreasing serum thyroxine by competing for serum protein thyroxine binding sites. (L127); This organochloride inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10); Pentachlorophenol inhibits mitochondrial ATP-ase activity, preventing the the formation of ATP and the release of energy to the cell from the breakdown of ATP to ADP. (A95); This organochloride antagonizes the action of the neurotransmitter gamma-aminobutyric acid (GABA) acting at the GABA-A receptors, effectively blocking the GABA-induced uptake of chloride ions and causing hyperexcitability of the central nervous system. (T10); Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590); Pentachlorophenol is an antagonist of progesterone receptor (PR). It inhibits the gene expression via the PR in a dose-dependent manner.",
      "aop": [
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            }
      ],
      "targets": [
            "Acetylcholinesterase",
            "Calcium-transporting ATPase type 2C member 1",
            "Calcium-transporting ATPase type 2C member 2",
            "Carnitine O-acetyltransferase",
            "Choline O-acetyltransferase",
            "Estrogen receptor alpha",
            "Estrogen receptor beta",
            "Estrogen-related receptor gamma",
            "Gamma-aminobutyric acid receptor subunit alpha-1",
            "Gamma-aminobutyric acid receptor subunit alpha-2",
            "Gamma-aminobutyric acid receptor subunit alpha-3",
            "Gamma-aminobutyric acid receptor subunit alpha-4",
            "Gamma-aminobutyric acid receptor subunit alpha-5",
            "Gamma-aminobutyric acid receptor subunit alpha-6",
            "Gamma-aminobutyric acid receptor subunit beta-1",
            "Gamma-aminobutyric acid receptor subunit beta-2",
            "Gamma-aminobutyric acid receptor subunit beta-3",
            "Gamma-aminobutyric acid receptor subunit delta",
            "Gamma-aminobutyric acid receptor subunit epsilon",
            "Gamma-aminobutyric acid receptor subunit gamma-1",
            "Gamma-aminobutyric acid receptor subunit gamma-2",
            "Gamma-aminobutyric acid receptor subunit gamma-3",
            "Gamma-aminobutyric acid receptor subunit pi",
            "Gamma-aminobutyric acid receptor subunit rho-1",
            "Gamma-aminobutyric acid receptor subunit rho-2",
            "Gamma-aminobutyric acid receptor subunit rho-3",
            "Gamma-aminobutyric acid receptor subunit theta",
            "Lysophosphatidylcholine acyltransferase 1",
            "Lysophosphatidylcholine acyltransferase 2",
            "Nuclear receptor ROR-beta",
            "Nuclear receptor ROR-gamma",
            "Nuclear receptor subfamily 1 group I member 2",
            "Peroxisome proliferator-activated receptor alpha",
            "Peroxisome proliferator-activated receptor gamma",
            "Plasma membrane calcium-transporting ATPase 1",
            "Plasma membrane calcium-transporting ATPase 2",
            "Plasma membrane calcium-transporting ATPase 3",
            "Plasma membrane calcium-transporting ATPase 4",
            "Potassium-transporting ATPase alpha chain 1",
            "Potassium-transporting ATPase alpha chain 2",
            "Potassium-transporting ATPase subunit beta",
            "Progesterone receptor",
            "Protein ATP1B4",
            "Proto-oncogene c-Fos",
            "Retinoic acid receptor gamma-2",
            "Sarcoplasmic/endoplasmic reticulum calcium ATPase 1",
            "Sarcoplasmic/endoplasmic reticulum calcium ATPase 2",
            "Sarcoplasmic/endoplasmic reticulum calcium ATPase 3",
            "Sodium/potassium-transporting ATPase subunit alpha-1",
            "Sodium/potassium-transporting ATPase subunit alpha-2",
            "Sodium/potassium-transporting ATPase subunit alpha-3",
            "Sodium/potassium-transporting ATPase subunit alpha-4",
            "Sodium/potassium-transporting ATPase subunit beta-1",
            "Sodium/potassium-transporting ATPase subunit beta-2",
            "Sodium/potassium-transporting ATPase subunit beta-3",
            "Sodium/potassium-transporting ATPase subunit gamma",
            "Sulfotransferase 1A1",
            "Sulfotransferase 1A2",
            "Sulfotransferase 1A3/1A4",
            "Thyroxine-binding globulin",
            "Transforming growth factor beta-1",
            "Transient receptor potential cation channel subfamily A member 1",
            "Transthyretin"
      ]
}